1.
Blood Cancer J
; 13(1): 65, 2023 05 03.
Article
in English
| MEDLINE | ID: covidwho-2317949
Subject(s)
COVID-19 , Myeloproliferative Disorders , Humans , Nitriles , Pyrimidines , Pyrazoles/therapeutic use
2.
Eur J Cancer
; 158: 251-252, 2021 11.
Article
in English
| MEDLINE | ID: covidwho-1509751
Subject(s)
COVID-19 , Neoplasms , COVID-19 Vaccines , Humans , Italy/epidemiology , SARS-CoV-2 , Vaccination , Vaccination Refusal
3.
Hemasphere
; 4(5): e483, 2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-1388046
4.
Clin Case Rep
; 9(6): e04013, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-1263064
ABSTRACT
Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID-19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID-19 can overcome the infection, also in hematological patients.